MEDIRAD – the first EURATOM project dedicated to researching the implications of medical low-dose radiation – specifically aims to enhance the scientific bases and clinical practice of radiation protection in the medical field and addresses the need to better understand and evaluate the health effects of low-dose ionising radiation exposure from diagnostic and therapeutic imaging, and from off-target effects in radiotherapy. MEDIRAD has three major operational objectives: 1) to improve organ dose estimation and registration; 2) to evaluate and understand the mechanisms of the effects...
Description of activity and work performed
The project is close to completing its third year and has achieved several major milestones including the setup and testing of a central DICOM repository for dosimetry, imaging meta-data, and biobanking. Data collection efforts for the first-ever establishment of European DRLs for specific applications of CT in nuclear medicine have just been finalised. Also, a fast Monte Carlo code MC-GPU has been validated to determine organ dose and skin dose distribution for interventional procedures. Moreover, the assessment of low dose radiation exposure from I-131 radioiodine...
Conclusion and recommendations
Medical radiation is an essential tool both in diagnosis and treatment in medicine. The use of ionising radiation in medicine has been steadily increasing, and this trend is set to continue, with obvious health benefits for the population thanks to improved diagnostic and therapy technologies. However, the increasing use of new modalities both for diagnosis and treatment also raises a number of issues in radiological protection of patients and medical workers, as the population’s average medical exposure levels are continually rising.
For the first time,...
The project is coordinated by EIBIR: firstname.lastname@example.org
This project has received funding from the Euratom research and training programme 2014-2018 under grant agreement No. 755523.
Disclaimer: This publication reflects only the author’s views. The European Union is not liable for any use that may be made of the information contained therein.